4-antibody AG

4-antibody AG aims to produce fully-human, "gold standard" antibodies using its unique combination of tested technologies. The trump card: it reckons it can skirt the IP blackout zone created by pioneers around well-validated targets, thereby opening up an alterrnative route into existing, billion-dollar antibody markets.